Brainstorm Cell Therapeutics, Inc. (BCLI)
1.065
-0.06
(-5.19%)
USD |
OTCM |
Aug 31, 16:00
Brainstorm Cell Therapeutics Net Income (TTM) : -10.52M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.52M |
| March 31, 2026 | -9.57M |
| December 31, 2025 | -10.31M |
| September 30, 2025 | -10.85M |
| June 30, 2025 | -11.45M |
| March 31, 2025 | -11.09M |
| December 31, 2024 | -11.62M |
| September 30, 2024 | -14.23M |
| June 30, 2024 | -12.75M |
| March 31, 2024 | -15.53M |
| December 31, 2023 | -17.19M |
| September 30, 2023 | -16.63M |
| June 30, 2023 | -22.26M |
| March 31, 2023 | -23.98M |
| December 31, 2022 | -24.28M |
| September 30, 2022 | -25.45M |
| June 30, 2022 | -23.93M |
| March 31, 2022 | -23.16M |
| December 31, 2021 | -24.46M |
| September 30, 2021 | -30.08M |
| June 30, 2021 | -29.23M |
| March 31, 2021 | -30.36M |
| December 31, 2020 | -31.81M |
| September 30, 2020 | -27.69M |
| June 30, 2020 | -28.83M |
| Date | Value |
|---|---|
| March 31, 2020 | -26.34M |
| December 31, 2019 | -23.25M |
| September 30, 2019 | -20.94M |
| June 30, 2019 | -18.49M |
| March 31, 2019 | -16.68M |
| December 31, 2018 | -13.95M |
| September 30, 2018 | -8.289M |
| June 30, 2018 | -7.516M |
| March 31, 2018 | -5.465M |
| December 31, 2017 | -4.952M |
| September 30, 2017 | -5.852M |
| June 30, 2017 | -5.055M |
| March 31, 2017 | -4.977M |
| December 31, 2016 | -4.982M |
| September 30, 2016 | -5.742M |
| June 30, 2016 | -6.739M |
| March 31, 2016 | -8.042M |
| December 31, 2015 | -8.488M |
| September 30, 2015 | -9.834M |
| June 30, 2015 | -9.652M |
| March 31, 2015 | -9.371M |
| December 31, 2014 | -9.246M |
| September 30, 2014 | -7.733M |
| June 30, 2014 | -6.394M |
| March 31, 2014 | -5.928M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| NovelStem International Corp. | -0.3076M |
| Summit Therapeutics, Inc. | -856.09M |
| Kezar Life Sciences, Inc. | -45.23M |
| Protara Therapeutics, Inc. | -70.02M |
| Clene, Inc. | -39.52M |